igeahub.com
New Clinical Results show Novartis' Entresto™ reduced cardiovascular death or hospitalization for heart failure - IgeaHub
April 2, 2016 New clinical analysis shows Novartis' Entresto™ reduced cardiovascular (CV) death or hospitalization for heart failure, steadily benefitting